- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: JNJ-61186372
Total 870 results
-
Janssen Research & Development, LLCCompletedCastration-Resistant Prostatic NeoplasmsCanada, Belgium, United States, Spain, Netherlands, Italy, Russian Federation
-
Janssen Research & Development, LLCRecruitingInvasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) PreventionUnited States, United Kingdom, Korea, Republic of, Taiwan, Canada, Denmark, France, Thailand, New Zealand, Spain, China, Israel, Germany, Colombia, India, Netherlands, Australia, Japan, Czechia, Sweden, Italy
-
Janssen Pharmaceutical K.K.Completed
-
Octimet Oncology N.V.Terminated
-
Janssen Research & Development, LLCWithdrawn
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Spain, Netherlands, Sweden, Denmark, France
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CancerUnited States, France, Germany, United Kingdom, Belgium, Taiwan, Spain, Israel, India, Romania, Korea, Republic of, Russian Federation, Turkey, Austria, Moldova, Republic of
-
Janssen Research & Development, LLCCompleted
-
ActelionTerminatedPulmonary Arterial HypertensionGermany, Korea, Republic of, Israel, Singapore, United States, Russian Federation, Brazil, Netherlands, Malaysia, Saudi Arabia, United Kingdom, Hong Kong, France, United Arab Emirates, Argentina
-
Janssen Research & Development, LLCCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedPain | Mononeuropathies | Neuralgia | Neuralgia, PostherpeticUnited States, Spain, Belgium, Netherlands
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCWithdrawn
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
CCTU-CoreJanssen PharmaceuticalsActive, not recruitingInflammation | Depressive Disorder, MajorUnited Kingdom
-
Janssen Research & Development, LLCTerminated
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Research & Development, LLCCompletedKidney Failure, ChronicUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedTraumatic Brain InjuryFrance, Belgium
-
Janssen Research & Development, LLCCompletedNeoplasmChina, Taiwan, Korea, Republic of
-
Janssen Research & Development, LLCPharmacyclics LLC.Completed
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Vaccines & Prevention B.V.CompletedHealthyUnited Kingdom, Germany, Spain, Netherlands
-
Janssen Research & Development, LLCCompletedDepressive Disorder, MajorUnited States, Bulgaria, Ukraine, Russian Federation, Germany, Finland, Japan, France
-
Janssen Research & Development, LLCCompletedTreatment Resistant Depressive DisorderUnited States, Japan, Belgium
-
Janssen Research & Development, LLCCompletedRespiratory Syncytial Virus InfectionsUnited States, Taiwan, Japan, Korea, Republic of, France, Mexico, Brazil, Sweden, Argentina, Ukraine, Canada, Spain, Germany, Poland, Belgium, Russian Federation, South Africa, Australia, Bulgaria
-
Janssen Research & Development, LLCCompletedLeukemia, Myeloid, AcuteUnited States, Australia, France, Poland, Taiwan, Belgium, Germany, United Kingdom, Spain, Israel, Turkey, Korea, Republic of, Russian Federation, Sweden
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Research & Development, LLCCompletedHepatitis B, ChronicFrance, Germany, Spain, Poland, Belgium
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedAlzheimer DiseaseFrance, Belgium, Germany, Spain, Sweden
-
Janssen Research & Development, LLCCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen BioPharma, Inc.Completed
-
Janssen Research & Development, LLCCompletedArthritis, RheumatoidPoland, Ukraine, Chile, Korea, Republic of, Singapore, Russian Federation, Argentina, Bulgaria, Hungary, Czech Republic
-
Janssen Pharmaceutical K.K.RecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorJapan
-
Janssen Research & Development, LLCRecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorKorea, Republic of, United States, Germany, Spain, Netherlands
-
Janssen Research & Development, LLCCompletedDepressive Disorder, MajorUnited States, Taiwan, Czechia, Spain, Mexico, South Africa, Colombia, Russian Federation, Brazil, Bulgaria, Sweden
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Research & Development, LLCCompleted